Kobo Biotech

3.00
+0.11
(3.81%)
Market Cap
7.16 Cr
EPS
-15.47
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
5.11
52 Week low
2.51
PB Ratio
-0.05
Debt to Equity
2.56
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
796.10 20,281.15 46.31 15,707.00 -7.64 449 -110.82 30.89
1,118.15 14,115.28 16.56 8,798.90 -22.71 457 318.35 54.17
482.40 7,088.42 13.99 8,398.90 -20.68 485 68.04 33.78
430.45 6,805.83 - 4,003.40 -20.27 -158 45.41 47.75
617.70 5,914.77 10.08 3,498.80 -23.68 794 68.74 44.13
807.00 4,317.46 - 21.50 10,650.00 2 62.50 58.72
89.38 4,052.62 25.03 1,099.90 9.90 146 0.70 45.47
516.10 3,790.51 - 3,896.70 -14.52 -237 90.27 28.55
3,086.35 3,078.62 38.74 385.20 0.60 53 244.55 44.54
237.37 2,430.39 - 2,102.50 -2.77 -39 -82.61 48.44
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-99.07 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
TTM
Revenue
103
0
Expenses
104
0
EBITDA
-1
0
Operating Profit %
-1 %
0 %
Depreciation
10
0
Interest
24
0
Profit Before Tax
-34
0
Tax
1
0
Net Profit
-35
0
EPS in ₹
-15.47
0.00

Balance Sheet

Balance Sheet
2015
Total Assets
396
Fixed Assets
104
Current Assets
290
Capital Work in Progress
2
Investments
0
Other Assets
290
Total Liabilities
396
Current Liabilities
264
Non Current Liabilities
79
Total Equity
53
Reserve & Surplus
31
Share Capital
23

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
-1
0
-1
0
0
0
1
-1
0
Investing Activities
0
0
0
0
0
0
0
25
0
Operating Activities
19
6
32
32
21
15
3
94
1
Financing Activities
-21
-5
-33
-32
-21
-15
-1
-120
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Promoter
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
46.99 %
46.95 %
47.02 %
46.84 %
46.81 %
46.81 %
46.65 %
46.65 %
47.70 %
47.75 %
47.86 %
47.97 %
48.27 %
Others
7.40 %
7.43 %
7.37 %
7.55 %
7.57 %
7.57 %
7.74 %
7.74 %
6.69 %
6.64 %
6.53 %
6.42 %
6.12 %
No of Share Holders
0
5,632
5,611
5,645
5,862
6,064
6,064
6,204
6,496
6,458
6,478
6,530
6,767

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Corporate Insolvency Resolution Process (CIRP)-Invitation of Resolution Plan
Feb 13, 2025, 19:54
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Feb 13, 2025, 19:44
Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)
Feb 11, 2025, 20:37
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Nov 20, 2024, 19:11
Corporate Insolvency Resolution Process (CIRP)-List of Creditors
Nov 05, 2024, 19:45
Corporate Insolvency Resolution Process (CIRP)-Public Announcement
Nov 05, 2024, 19:37
Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)
Nov 05, 2024, 19:26
Corporate Insolvency Resolution Process (CIRP)-Initiation of Corporate Insolvency Resolution Process (CIRP) by Financial Creditors
Nov 05, 2024, 19:14
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Oct 10, 2024, 17:02
Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
Aug 16, 2024, 15:35
Unaudited Financial Results For The Quarter Ended 30Th June, 2024.
Aug 14, 2024, 14:44
Board Meeting Intimation for Board Meeting For The Approval Of Unaudited Financial Statement For The Quarter Ended 30Th June, 2024
Aug 12, 2024, 17:40
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 20, 2024, 13:32
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Jun 28, 2024, 11:16
Closure of Trading Window
Jun 26, 2024, 15:04
Stay On The NCLT Order Dated 15Th May, 2024 Of M/S. Arch Pharmalabs Limited (Promoter Entity)
May 31, 2024, 16:58
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 30, 2024, 17:45
Announcement under Regulation 30 (LODR)-Resignation of Director
May 30, 2024, 16:01
Audited Financial Results For The Quarter And Year Ended 31St March, 2024.
May 30, 2024, 15:55
Board Meeting Outcome for Submission Of The Audited Financial Results For The Quarter And The Year Ended 31St March, 2024 Along With The Report Of Statutory Auditor Thereon.
May 30, 2024, 15:50
Board Meeting Intimation for Approval Of Financial Statement
May 23, 2024, 12:39
Admission Of Application Under Section 7 Of Insolvency And Bankruptcy Code, 2016 Against M/S. Arch Pharmalabs Limited (Promoter Entity)
May 17, 2024, 13:03
Compliance Certificate Under Regulation 7(3)
Apr 26, 2024, 16:30
Certificate Pursuant To Regulation 40(9) Of SEBI LODR
Apr 20, 2024, 14:34
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 20, 2024, 14:29
Closure of Trading Window
Mar 28, 2024, 16:30
Financial Result For The Quarter And Nine Months Ended 31St December, 2023
Feb 14, 2024, 18:40
Board Meeting Intimation for Approval Of The Unaudited Financial Statements For The Quarter And Nine Months Ended 31St December 2023.
Feb 07, 2024, 16:00
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jan 23, 2024, 13:53
Closure of Trading Window
Dec 28, 2023, 10:38
Related Party Transaction For The Hald Year Ended 30-09-2023
Nov 10, 2023, 16:29
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2023
Nov 10, 2023, 16:24
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday, 10Th November, 2023.
Nov 03, 2023, 10:38
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 17, 2023, 14:10
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Oct 03, 2023, 14:04
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 30, 2023, 14:52
Closure of Trading Window
Sep 30, 2023, 11:26
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 12, 2023, 10:52
Reg. 34 (1) Annual Report.
Sep 09, 2023, 11:16
30Th Annual Report For The Financial Year 2022-23
Sep 09, 2023, 11:08
Notice Of The 30Th Annual General Meeting Of The Company For The Financial Year 2022-23 To Be Held On Saturday, The 30Th Day Of September, 2023 At 10.00 A.M
Sep 09, 2023, 11:05
Announcement under Regulation 30 (LODR)-Change in Directorate
Aug 11, 2023, 16:37
Unaudited Financial Results For The Quarter Ended 30Th June, 2023.
Aug 11, 2023, 16:31
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
Aug 11, 2023, 16:26
Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The 1St Quarter Ended 30Th June, 2023.
Aug 03, 2023, 17:04
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 15, 2023, 14:52
Closure of Trading Window
Jun 30, 2023, 16:03
Compliances-Reg.24(A)-Annual Secretarial Compliance
Jun 01, 2023, 15:40
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 30, 2023, 22:06
Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023
May 30, 2023, 17:51

Technical Indicators

RSI(14)
Neutral
46.04
ATR(14)
Volatile
0.22
STOCH(9,6)
Neutral
62.01
STOCH RSI(14)
Neutral
79.05
MACD(12,26)
Bullish
0.03
ADX(14)
Weak Trend
20.69
UO(9)
Bearish
58.83
ROC(12)
Uptrend But Slowing Down
4.33
WillR(14)
Neutral
-37.70